Reply to Comment on “Efficacy of Sublingual Lorazepam for Prolonged Convulsions Beyond Sub-Saharan Africa”

Abstract

Get full access to this article

View all access options for this article.

References

Muchohi

Obiero

Newton

. Pharmacokinetics and clinical efficacy of lorazepam in children with severe malaria and convulsions. Br J Clin Pharmacol. 2008;65:12–21.

Arya

Gulati

Kabra

. Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study. Epilepsia. 2011;52:788–793.

Qureshi

wassemer

Davies

. Comparative audit of intravenous lorazepam and diazepam in the emergency treatment of convulsive status epilepticus in children. Seizures. 2002;11:141–144.

Anderson

Tambe

Sammons

. Pharmacokinetics of buccal and intranasal lorazepam in healthy adult volunteers. Eur J Clin Pharmacol. 2012;68:155–159.

Srinivas

. Buccal and intranasal lorazepam clinical pharmacokinetics: can it adequately compete with intravenous lorazepam in pediatric care patients? Eur J Clin Pharmacol. 2012;68:1221–1223.

Troester

Hastriter

. Dissolving oral clonazepam wafers in the acute treatment of prolonged seizures. J Child Neurol. 2010;25:1468–1472.

Cloyd

. Pharmacologic consideration in the treatment of repetitive or prolonged seizures. J Child Neurol. 2007;22:47s–52s.

Winkler

Tluway

Schmutzhard

. Febrile seizures in rural Tanzania: hospital-based incidence and clinical characteristics. J Trop Pediatr. 2013;59:298–304.